Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | September 29, 2023 01:31pm

Gainers

  • Femasys (NASDAQ:FEMY) stock increased by 104.9% to $3.12 during Friday's regular session. Trading volume for Femasys's stock is 132.6 million as of 13:30 EST. This is 1827.7% of its average full-day volume over the last 100 days. The company's market cap stands at $46.9 million.
  • OpGen (NASDAQ:OPGN) stock increased by 77.96% to $0.36. Trading volume for OpGen's stock is 83.1 million as of 13:30 EST. This is 21356.5% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 64.07% to $0.33. As of 13:30 EST, Novo Integrated Sciences's stock is trading at a volume of 168.4 million, which is 364.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.4 million.
  • SeaStar Medical Holding (NASDAQ:ICU) shares moved upwards by 39.09% to $0.26. Trading volume for this security as of 13:30 EST is 51.9 million, which is 8276.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.0 million.
  • Evoke Pharma (NASDAQ:EVOK) shares rose 37.96% to $1.49. Evoke Pharma's stock is trading at a volume of 59.6K shares as of 13:30 EST. This is 512.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.9 million.
  • Structure Therapeutics (NASDAQ:GPCR) shares rose 33.31% to $49.95. Trading volume for this security as of 13:30 EST is 7.6 million, which is 1571.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.

Losers

  • Capricor Therapeutics (NASDAQ:CAPR) shares fell 41.4% to $3.41 during Friday's regular session. As of 13:30 EST, Capricor Therapeutics's stock is trading at a volume of 2.1 million, which is 1745.2% of its average full-day volume over the last 100 days. The company's market cap stands at $87.8 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock decreased by 40.28% to $0.26. The current volume of 5.6 million shares is 5485.8% of Reshape Lifesciences's average full-day volume over the last 100 days (last updated at 13:30 EST).
  • Vaccinex (NASDAQ:VCNX) shares decreased by 28.53% to $1.08. Trading volume for Vaccinex's stock is 1.1 million as of 13:30 EST. This is 1154.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.9 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) stock decreased by 21.62% to $0.55. Trading volume for this security as of 13:30 EST is 2.0 million, which is 494.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million.
  • Corcept Therapeutics (NASDAQ:CORT) shares decreased by 16.95% to $27.4. As of 13:30 EST, this security is trading at a volume of 3.5 million shares, making up 576.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 billion.
  • Baudax Bio (NASDAQ:BXRX) stock declined by 16.42% to $0.38. Trading volume for Baudax Bio's stock is 4.7 million as of 13:30 EST. This is 101.3% of its average full-day volume over the last 100 days. The company's market cap stands at $3.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BXRX CAPR CORT EVOK FEMY GPCR ICU NVOS OPGN RSLS TNXP VCNX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist